C88 Malignant immunoproliferative diseases

(Malignant immunoproliferative diseases )

Rare males and females disease from the section "Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue". Causes not a significant loss of workdays. May be the cause of death.

80 744 people were diagnosed with Malignant immunoproliferative diseases

10 536 died with a diagnosis of Malignant immunoproliferative diseases

0.13 % disease mortality Malignant immunoproliferative diseases

Malignant immunoproliferative diseases is diagnosed to men at 47.61% more often than women

48 135

Men are diagnosed with Malignant immunoproliferative diseases. For 5 852 of them, this diagnosis is fatal

0.12 %

mortality in men with disease Malignant immunoproliferative diseases

95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0

32 609

Women are diagnosed with Malignant immunoproliferative diseases For 4 684 of these, this diagnosis is fatal.

0.14 %

mortality in women with disease Malignant immunoproliferative diseases

Risk group for the disease Malignant immunoproliferative diseases men aged 60-64 and women aged75-79

The disease is most common in men aged 60-64

In men, the disease is least likely to occur at the age of 0-1, 5-14, 20-24, 35-39, 95+

In women, the disease is least likely to occur at the age of 0-4, 10-24, 35-39

The disease is most common in women aged 75-79

Features of the disease Malignant immunoproliferative diseases

Absence or low individual and social danger

Diagnostics

3 standard for the diagnosis of Malignant immunoproliferative diseases

Diagnosis Malignant immunoproliferative diseases on the 9 place in the frequency of diseases in the rubric of other Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue diseases

Most common:

Malignant immunoproliferative diseases disease on the 9 most dangerous disease in the category of other Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue diseases

Most dangerous:


Treatment

3 standard for the treatment of Malignant immunoproliferative diseases

6 days required for doctors in inpatient treatment

7 hour(s) is required for outpatient treatment

0 medical procedures are provided for the treatment of Malignant immunoproliferative diseases

Diseases with similar symptoms

Single spontaneous delivery

Single spontaneous delivery ,

One of the most popular female diseases from the section "Delivery". Causes not a significant loss of workdays. Not mortally.

Low risk, only women get sick, age 13-57

Liveborn infants according to place of birth

Liveborn infants according to place of birth ,

One of the most popular males and females diseases from the section "Persons encountering health services in circumstances related to reproduction". Causes not a significant loss of workdays. Not mortally.

Low risk, sick men and women, age 0-0

Fall on same level from slipping, tripping and stumbling

Fall on same level from slipping, tripping and stumbling ,

One of the most popular males and females diseases from the section "Falls". Causes not a significant loss of workdays. May be the cause of death.

Medium risk, sick men and women, age 1-100

Heart failure

Heart failure ,

One of the most popular males and females diseases from the section "Other forms of heart disease". Causes not a significant loss of workdays. May be the cause of death.

High risk, sick men and women, any age

Possible Symptoms